Published Sep 8, 2026, 10:26 AM ET · Updated 2 months ago · 1 source
Amgen drops on Novartis trial setback for heart therapy; BMO downgrades
Seeking Alpha
·
Original Report
Amgen drops on Novartis trial setback for heart therapy; BMO downgrades
Amgen drops on Novartis trial setback for heart therapy; BMO downgrades